Surgery Partners, Inc. (SGRY) Misses Q4 EPS by 18c; offers guidance

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q4 EPS of $0.12, $0.18 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $885 million versus the consensus estimate of $866.79 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2026 revenue of $3.35-3.45 billion, versus the consensus of $3.562 billion.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• Sanuwave Q2 2026 revenue tops revised guidance range
• Penguin Solutions plans $650M convertible notes offering due 2031
• Lode Gold plans $7M private placement with Coast Capital follow-on